Medicure (TSE:MPH) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Medicure Inc. reported a slight increase in total net revenue for Q3 2024, reaching $5.2 million compared to $5.0 million in the same quarter last year. Despite a drop in AGGRASTAT sales, the company experienced growth in revenue from its Marley Drug business, contributing to a notable rise in net income to $680,000 from the previous year’s $84,000.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.
